Crop Life Science Ltd (CLSL) is currently trading at 88.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Crop Life Science Limited manufactures, distributes and markets a wide range of agrochemical formulations including pesticides, insecticides, herbicides, fungicides, plant growth regulators and micro fertilizers; it operates a manufacturing unit at GIDC Ankleshwar, exports products to multiple countries and reports a broad portfolio of over eighty-five proprietary and contract-manufactured products across two business segments. Financially, the company reported standalone revenue of INR 12,027.25 lakhs for H1 ended September 30, 2025, up materially versus prior comparable periods, while H1 PAT stood at INR 322.43 lakhs; consolidated H1 revenue and profitability show similar trends with an exceptional gain from sale of GIDC land recognised as a one-off item of INR 29.63 lakhs. The balance sheet displays a sharp increase in current liabilities and short-term borrowings with consolidated short-term borrowings rising to INR 5,200.08 lakhs, signalling elevated working capital utilisation; meanwhile cash and cash equivalents improved in the half, driven partly by land sale proceeds and working-capital movements, producing mixed liquidity signals that require monitoring. Strategically the company maintains manufacturing plus trading segments, inaugurated a Biological R&D laboratory in 2021, expanded international exports since 2012 and created a subsidiary (Hetban Spechem Limited) in March 2024; it also completed a fresh equity IPO in August 2023 raising about INR 26.72 crore, which underpins growth capital and balance sheet strengthening. A notable non-operating development was the sale of GIDC industrial land during the half, where proceeds of INR 344.99 lakhs and transfer of the related loan liability materially altered asset composition and produced an exceptional item; this transaction reduces a legacy liability but does not change core manufacturing operations or product mix.

Over the past 52 weeks, Crop Life Science Ltd has traded between a low of ₹39.05 and a high of ₹92.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Crop Life Science Ltd has a market capitalization of approximately 147.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Crop Life Science Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 147.49 Cr, Crop Life Science Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Crop Life Science Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Crop Life Science Ltd is 22.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.